Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Indraprastha MedicalBOM:532150 -0.18%79 ROC (Joel Greenblatt) % is 82.98% as of Jun. 2026, which is 266% above its 10-year median of 22.67. GuruFocus rates BOM:532150 with a GF Score™ of 79/100 and a GF Value™ of ₹426.30 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 678 Healthcare Providers & Services companies, Indraprastha Medical ranks better than 85.4% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Indraprastha Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 82.98%.
The historical rank and industry rank for Indraprastha Medical's ROC (Joel Greenblatt) % or its related term are showing as below:
BOM:532150'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 1.46 Med: 22.67 Max: 71.76
Current: 71.76
During the past 13 years, Indraprastha Medical's highest ROC (Joel Greenblatt) % was 71.76%. The lowest was 1.46%. And the median was 22.67%.
BOM:532150's ROC (Joel Greenblatt) % is ranked better than 85.4% of 678
companies
in the Healthcare Providers & Services industry
Industry Median: 11.97
vs BOM:532150: 71.76
Indraprastha Medical's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 86.30% per year.
Indraprastha Medical (BOM:532150) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Indraprastha Medical ROC (Joel Greenblatt) % Related Terms
Indraprastha Medical ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Indraprastha Medical's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indraprastha Medical ROC (Joel Greenblatt) % Chart
BOM:532150 vs HCA, THC, EHC: ROC (Joel Greenblatt) % Comparison
For the Medical Care Facilities subindustry, Indraprastha Medical's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indraprastha Medical ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Indraprastha Medical's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Indraprastha Medical's ROC (Joel Greenblatt) % falls into.
Indraprastha Medical ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 82.98% mean?
Indraprastha Medical (BOM:532150) has a ROC (Joel Greenblatt) % of 82.98% as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Indraprastha Medical and its competitors. This is 266% above median its historical median of 22.67. Over the past decade, Indraprastha Medical's ROC (Joel Greenblatt) % has ranged from 1.46 to 71.76. According to the industry distribution chart, Indraprastha Medical ranks #99 out of 678 companies in the Healthcare Providers & Services industry, placing it in the top 14.6%.
Is Indraprastha Medical's ROC (Joel Greenblatt) % too high?
Indraprastha Medical's current ROC (Joel Greenblatt) % of 82.98% is 266% above median its 10-year median of 22.67. Over the past 10 years, this metric has ranged from a low of 1.46 to a high of 71.76. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 11.97. Indraprastha Medical's value of 82.98% is 593.2% above this industry median. Based on the distribution chart, Indraprastha Medical ranks #99 out of 678 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Indraprastha Medical has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Indraprastha Medical's ROC (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Indraprastha Medical ranks #99 out of 678 companies for ROC (Joel Greenblatt) %. This places Indraprastha Medical in the top 15% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 11.97. Indraprastha Medical's value of 82.98% is 593.2% above this benchmark. Historically, Indraprastha Medical's own ROC (Joel Greenblatt) % has ranged from 1.46 to 71.76 over the past decade. While the company's 10-year median is 22.67 vs. the industry median of 11.97, Indraprastha Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 11.97, based on 678 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indraprastha Medical's current ROC (Joel Greenblatt) % of 82.98% is 593.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Indraprastha Medical and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 11.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indraprastha Medical's current ROC (Joel Greenblatt) % is 82.98%, which is 266% above median its own 10-year median of 22.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indraprastha Medical stock overvalued right now?
Based on GuruFocus' analysis, Indraprastha Medical (BOM:532150) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹426.30, compared to a current price of ₹367.15 — trading 13.9% below its estimated fair value. The current ROC (Joel Greenblatt) % is 82.98%, which is 266% above median its 10-year median of 22.67 and 593.2% above the Healthcare Providers & Services industry median of 11.97. Indraprastha Medical's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Indraprastha Medical (BOM:532150), the current ROC (Joel Greenblatt) % is 82.98% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indraprastha Medical (BOM:532150) Overvalued in 2026?
Based on GuruFocus' analysis, Indraprastha Medical stock appears to be undervalued.
The current stock price of ₹367.15 is trading 13.9% below its estimated GF Value™ of ₹426.30.
GuruFocus considers Indraprastha Medical to be Modestly Undervalued.
Key valuation signals for BOM:532150:
ROC (Joel Greenblatt) %: 82.98% (266% above median its 10-year median of 22.67)
GF Value™: ₹426.30 vs. price of ₹367.15 (13.9% below fair value)
Industry Position: 593.2% above the Healthcare Providers & Services median (#99 of 678)
No single metric tells the full story. See the BOM:532150 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indraprastha Medical Corp Ltd is an Indian company that operates in the healthcare business. It offers services in the field of anaesthesiology, pediatrics, bone marrow transplant, dental surgery, neonatology, dermatology, obesity, and metabolic surgery, orthopaedics, robotic surgery, spine surgery and in many other areas. The company also provides diagnosis, treatment, and management of various hormonal disorders; and inpatient and ambulatory care services. Geographically all the business activities of the group are carried out through the regions of India. It derives revenue from the provision of services.
79GF Score
Get the complete analysis for BOM:532150
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532150 has been successfully added to your 
